Domestic avian influenza vaccine acquired approval, competing against the GSK’s product
An avian influenza vaccine developed by the domestic technology of Green Cross was approved by the Ministry of Food and Drug Safety(MFDS). It was the first time for a domestic avian vaccine to be approved; thus, dependency of Korea in vaccines is expected to increase.
The MFDS announced approval...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
